Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reductive activation of mitomycin A by thiols.

M M Paz1, M Tomasz

  • 1Department of Chemistry, Hunter College, City University of New York, New York, New York 10021, USA.

Organic Letters
|September 1, 2001
PubMed
Summary

Mitomycin A (MA) activates through a novel reductive mechanism involving thiols, unlike Mitomycin C. This process generates reactive electrophiles and mitosene derivatives, offering insights into drug activation pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.

Biochemistry·2001
Same author

Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potential.

Journal of medicinal chemistry·2001
Same author

Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.

Biochemical pharmacology·2001
Same author

Monoalkylation of DNA by reductively activated FR66979.

Bioorganic & medicinal chemistry·2000
Same author

Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells.

Chemical research in toxicology·2000
Same author

Mitomycin C linked to DNA minor groove binding agents: synthesis, reductive activation, DNA binding and cross-linking properties and in vitro antitumor activity.

Bioorganic & medicinal chemistry·2000

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Mitomycin C is a stable chemotherapeutic agent.
  • Mitomycin A (MA) is a more toxic variant of Mitomycin C.
  • The activation mechanisms of mitomycins are crucial for their therapeutic efficacy and toxicity.

Purpose of the Study:

  • To elucidate the activation mechanism of Mitomycin A (MA).
  • To investigate the role of thiols in MA activation.
  • To differentiate the reactivity of MA from Mitomycin C.

Main Methods:

  • Exposure of MA to thiols under physiological conditions.
  • Analysis of reaction products to identify mitosene derivatives.
  • Spectroscopic and chemical analyses to characterize reaction intermediates and mechanisms.

Main Results:

  • Mitomycin C remained unchanged when exposed to thiols.
  • Mitomycin A (MA) underwent elimination of methanol, forming various mitosene derivatives.
  • A novel reductive activation pathway for MA was identified, involving transient thiol addition to the quinone ring.
  • This mechanism leads to the formation of a reduced quinone and an oxidized thiol.

Conclusions:

  • Mitomycin A (MA) activates via a distinct reductive pathway involving thiols.
  • This activation mechanism generates reactive electrophilic species.
  • Understanding this pathway is key to developing targeted therapies and managing toxicity.

Related Experiment Videos